Clinical Trial Update: PHA-739358 for the Treatment of Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial of PHA-739358 for multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PHA-739358

Snippet

Sponsor: Nerviano Medical Sciences | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED